Cite
HARVARD Citation
Ricardo McFaline-Figueroa, J. et al. (n.d.). CTIM-25. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT. Neuro-oncology. pp. vii65-vii66. [Online].